Article info
PDFEditorial
Airway microbiome studies challenge simplistic models of inhaled tobramycin benefit
- Correspondence to Dr Geraint B Rogers, Microbiome Research, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia; geraint.rogers{at}sahmri.com
Citation
Airway microbiome studies challenge simplistic models of inhaled tobramycin benefit
Publication history
- Accepted October 9, 2020
- First published November 2, 2020.
Online issue publication
November 16, 2020
Article Versions
- Previous version (2 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.